Back

Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: From epidemiology to outcomes Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Daan Ceelen

University Medical Centre Groningen, Groningen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Obesity and inactivity cluster is the strongest predictor of incident heart failure in a population-based study
Mr B. Van Essen (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
comparing diagnostic modalities and time to diagnosis in transthyretin amyloidosis: insights from a multi-ethnic asian registry
Doctor V. Putri (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation is associated with worse outcome in patients with wild-type transthyretin amyloid cardiomyopathy
Assistant Professor G. Zemljic (Ljubljana, SI)
Abstract Slides Video
Presentation thumbnail
Diabetes, cancer and heart failure: a network of reciprocal epidemiological interactions with prognostic implications
Doctor A. Iaconelli (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Cardiopulmonary resuscitation preferences among elderly patients admitted for heart failure
Doctor P. Salamanca Bautista (Seville, ES)
Abstract Slides Video

Access the full session

Session thumbnail
From epidemiology to outcomes

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Clinical outcomes and prognostic implications of residual congestion at discharge in acute heart failure
thumbnail
Congress Presentation
Residual congestion assessment: in search of the Holy Grail
thumbnail
Congress Presentation
Residual subclinical congestion evaluated through non-invasive techniques in hospitalized patients with acute heart failure and association with outcomes: an analysis from a prospective single-centre

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources